- Home
- CHGG vs OBIO Comparison
CHGG vs OBIO Comparison
Compare CHGG & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- OBIO
- Stock Information
- Founded
- CHGG 2005
- OBIO 2017
- Country
- CHGG United States
- OBIO United States
- Employees
- CHGG N/A
- OBIO N/A
- Industry
- CHGG Other Consumer Services
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- CHGG Real Estate
- OBIO Health Care
- Exchange
- CHGG Nasdaq
- OBIO Nasdaq
- Market Cap
- CHGG 175.2M
- OBIO 156.6M
- IPO Year
- CHGG 2013
- OBIO N/A
- Fundamental
- Price
- CHGG $1.48
- OBIO $5.28
- Analyst Decision
- CHGG Hold
- OBIO Strong Buy
- Analyst Count
- CHGG 10
- OBIO 5
- Target Price
- CHGG $4.56
- OBIO $15.80
- AVG Volume (30 Days)
- CHGG 3.0M
- OBIO 182.8K
- Earning Date
- CHGG 02-03-2025
- OBIO 11-12-2024
- Dividend Yield
- CHGG N/A
- OBIO N/A
- EPS Growth
- CHGG N/A
- OBIO N/A
- EPS
- CHGG N/A
- OBIO N/A
- Revenue
- CHGG $662,077,000.00
- OBIO $2,647,000.00
- Revenue This Year
- CHGG N/A
- OBIO $22.61
- Revenue Next Year
- CHGG N/A
- OBIO $16.64
- P/E Ratio
- CHGG N/A
- OBIO N/A
- Revenue Growth
- CHGG N/A
- OBIO N/A
- 52 Week Low
- CHGG $1.34
- OBIO $3.96
- 52 Week High
- CHGG $10.50
- OBIO $10.06
- Technical
- Relative Strength Index (RSI)
- CHGG 38.42
- OBIO 50.69
- Support Level
- CHGG $1.43
- OBIO $5.00
- Resistance Level
- CHGG $1.79
- OBIO $5.70
- Average True Range (ATR)
- CHGG 0.13
- OBIO 0.57
- MACD
- CHGG -0.01
- OBIO 0.05
- Stochastic Oscillator
- CHGG 11.36
- OBIO 56.41
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.